Inogen Revenue 2012-2024 | INGN
Inogen revenue from 2012 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Inogen Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $316 |
| 2022 | $377 |
| 2021 | $358 |
| 2020 | $308 |
| 2019 | $362 |
| 2018 | $358 |
| 2017 | $249 |
| 2016 | $203 |
| 2015 | $159 |
| 2014 | $113 |
| 2013 | $75 |
| 2012 | $49 |
| 2011 | $31 |
| Inogen Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-06-30 | $89 |
| 2024-03-31 | $78 |
| 2023-12-31 | $76 |
| 2023-09-30 | $84 |
| 2023-06-30 | $84 |
| 2023-03-31 | $72 |
| 2022-12-31 | $88 |
| 2022-09-30 | $105 |
| 2022-06-30 | $103 |
| 2022-03-31 | $80 |
| 2021-12-31 | $76 |
| 2021-09-30 | $93 |
| 2021-06-30 | $102 |
| 2021-03-31 | $87 |
| 2020-12-31 | $74 |
| 2020-09-30 | $74 |
| 2020-06-30 | $72 |
| 2020-03-31 | $88 |
| 2019-12-31 | $79 |
| 2019-09-30 | $92 |
| 2019-06-30 | $101 |
| 2019-03-31 | $90 |
| 2018-12-31 | $87 |
| 2018-09-30 | $95 |
| 2018-06-30 | $97 |
| 2018-03-31 | $79 |
| 2017-12-31 | $64 |
| 2017-09-30 | $69 |
| 2017-06-30 | $64 |
| 2017-03-31 | $53 |
| 2016-12-31 | $51 |
| 2016-09-30 | $54 |
| 2016-06-30 | $55 |
| 2016-03-31 | $43 |
| 2015-12-31 | $40 |
| 2015-09-30 | $41 |
| 2015-06-30 | $44 |
| 2015-03-31 | $34 |
| 2014-12-31 | $29 |
| 2014-09-30 | $29 |
| 2014-06-30 | $30 |
| 2014-03-31 | $24 |
| 2013-12-31 | $20 |
| 2013-09-30 | $20 |
| 2013-06-30 | $20 |
| 2013-03-31 | $16 |
| 2012-12-31 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.218B | $0.316B |
| Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.217B | 26.40 |
| Intuitive Surgical (ISRG) | United States | $182.570B | 95.45 |
| Alcon (ALC) | Switzerland | $46.617B | 32.82 |
| Edwards Lifesciences (EW) | United States | $42.535B | 27.26 |
| IQVIA Holdings (IQV) | United States | $41.621B | 23.59 |
| IDEXX Laboratories (IDXX) | United States | $37.688B | 45.34 |
| DexCom (DXCM) | United States | $29.045B | 41.42 |
| STERIS (STE) | Ireland | $21.809B | 25.45 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.693B | 0.00 |
| Waters (WAT) | United States | $19.784B | 29.49 |
| Hologic (HOLX) | United States | $18.895B | 20.54 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.347B | 13.84 |
| Sysmex ADR (SSMXY) | Japan | $11.562B | 36.26 |
| Teleflex (TFX) | United States | $11.205B | 17.42 |
| Globus Medical (GMED) | United States | $10.005B | 27.99 |
| Penumbra (PEN) | United States | $7.913B | 82.14 |
| Masimo (MASI) | United States | $7.553B | 40.45 |
| Glaukos (GKOS) | United States | $7.140B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.243B | 24.81 |
| TransMedics (TMDX) | United States | $3.958B | 169.51 |
| PROCEPT BioRobotics (PRCT) | United States | $3.496B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.878B | 16.88 |
| Nihon Kohden (NHNKY) | Japan | $2.633B | 16.38 |
| Inari Medical (NARI) | United States | $2.570B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.506B | 20.41 |
| Veracyte (VCYT) | United States | $2.493B | 154.52 |
| Tandem Diabetes Care (TNDM) | United States | $2.105B | 0.00 |
| RxSight (RXST) | United States | $1.794B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.483B | 6.75 |
| Artivion (AORT) | United States | $1.125B | 103.31 |
| Pulse Biosciences (PLSE) | United States | $1.032B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.028B | 18.34 |
| OPKO Health (OPK) | United States | $1.018B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.721B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.649B | 16.39 |
| IRadimed (IRMD) | United States | $0.640B | 34.58 |
| OrthoPediatrics (KIDS) | United States | $0.625B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.598B | 0.00 |
| AxoGen (AXGN) | United States | $0.575B | 0.00 |
| SiBone (SIBN) | United States | $0.531B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.477B | 0.00 |
| Paragon 28 (FNA) | United States | $0.423B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.339B | 10.35 |
| ClearPoint Neuro (CLPT) | United States | $0.339B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.316B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.311B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.272B | 0.00 |
| CVRx (CVRX) | United States | $0.222B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.185B | 12.98 |
| Atossa Genetics (ATOS) | United States | $0.184B | 0.00 |
| Nevro (NVRO) | United States | $0.183B | 0.00 |
| Accuray (ARAY) | United States | $0.175B | 0.00 |
| NeuroPace (NPCE) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.157B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.121B | 0.00 |
| 908 Devices (MASS) | United States | $0.118B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.104B | 15.46 |
| WORK Medical Technology Group (WOK) | China | $0.091B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.075B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| LENSAR (LNSR) | United States | $0.065B | 0.00 |
| InspireMD (NSPR) | Israel | $0.062B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 0.00 |
| Envoy Medical (COCH) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Precision Optics (POCI) | United States | $0.025B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.025B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.024B | 0.00 |
| Spectral AI (MDAI) | United States | $0.023B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.016B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |